Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?

被引:26
|
作者
Reichman, David E. [1 ]
Chung, Pak [1 ]
Meyer, Laura [1 ]
Greenwood, Eleni [2 ]
Davis, Owen [1 ]
Rosenwaks, Zev [1 ]
机构
[1] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA
[2] Weill Cornell Med Ctr, New York, NY 10021 USA
关键词
IVF; consecutive cycles; time interval; OVARIAN HYPERSTIMULATION SYNDROME; GNRH ANTAGONIST; LUTEAL SUPPORT; STIMULATION; PROTOCOL; AGONIST; TRIGGER;
D O I
10.1016/j.fertnstert.2012.11.044
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether patients who failed an in vitro fertilization (IVF) cycle can proceed with a subsequent IVF cycle after waiting only one menstrual cycle, or whether there is a benefit to allowing two or more menstrual cycles to elapse before proceeding. Design: Retrospective cohort study. Setting: Academic medical center. Patient(s): All patients undergoing IVF cycles at The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, from January 1, 2002 to November 1, 2011, in whom two consecutive gonadotropin-releasing hormone (GnRH)-antagonist IVF cycles with identical stimulation protocols took place 35-140 days apart, excluding patients in whom the first cycle resulted in a clinical pregnancy. Intervention(s): None. Main Outcome Measure(s): IVF outcomes were compared for 164 patients who initiated a cycle after waiting only one menstrual cycle (35-55 days from previous oocyte retrieval) versus 557 patients waiting two or more menstrual cycles (56-140 days) from their last retrieval before proceeding with their successive cycle start, stratifying for age. Result(s): No differences were detected regarding E-2 response, oocyte yield, fertilization, or embryo development when comparing patients waiting only one cycle with those waiting two or more cycles, nor were those parameters different when comparing patients' index cycles with their immediate preceding failed cycles. Moreover, clinical outcomes regarding clinical pregnancy, live birth, and cycle cancellation were similar between both study groups. Conclusion(s): Delaying successive IVF cycle start for two or more menstrual cycles likely offers no advantage over pursuing repeated IVF after one menstrual cycle. (Fertil Steril (R) 2013; 99:1277-82. (C) 2013 by American Society for Reproductive Medicine.)
引用
收藏
页码:1277 / 1282
页数:6
相关论文
共 50 条
  • [31] Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?
    Delvigne, A
    Carlier, C
    Rozenberg, S
    FERTILITY AND STERILITY, 2001, 76 (04) : 844 - 846
  • [32] Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure
    Fisch, Jeffrey D.
    Keskintepe, Levent
    Sher, Geoffrey
    FERTILITY AND STERILITY, 2008, 89 (02) : 342 - 347
  • [33] Effects of letrozole co-treatment on outcomes of gonadotropin-releasing hormone antagonist cycles in POSEIDON groups 3 and 4 expected poor responders
    Kahraman, Alper
    Tulek, Firat
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (04) : 1313 - 1319
  • [34] Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
    Chen, Qiuju
    Chai, Weiran
    Wang, Yun
    Cai, Renfei
    Zhang, Shaozhen
    Lu, Xuefeng
    Zeng, Xiaojing
    Sun, Lihua
    Kuang, Yanping
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [35] The use of lead follicle diameter to initiate gonadotropin-releasing hormone antagonist does not affect in vitro fertilization clinical pregnancy, implantation, or live birth rates: a prospective, randomized study
    Dayal, Molina B.
    Frankfurter, David
    O'Hern, Candice
    Peak, Douglas
    Dubey, Anil
    Gindoff, Paul R.
    FERTILITY AND STERILITY, 2009, 92 (06) : 2047 - 2049
  • [36] Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?
    Guivarc'h-Leveque, Anne
    Homer, Lionel
    Arvis, Philippe
    Broux, Pierre Louis
    Moy, Ludovic
    Priou, Gerard
    Vialard, Jean
    Colleu, Daniel
    Dewailly, Didier
    FERTILITY AND STERILITY, 2011, 96 (04) : 872 - 876
  • [37] Association between luteinizing hormone level decrease on the triggering day and pregnancy outcome for in vitro fertilization/intracytoplasmic sperm injection patients following gonadotropin-releasing hormone antagonist protocol: a retrospective cohort study
    Li, Qing-Fang
    Tang, Min-Yue
    Wang, Gui-Quan
    Chen, Xi-Jing
    Feng, Guo-Fang
    Zhu, Yi-Min
    REPRODUCTIVE AND DEVELOPMENTAL MEDICINE, 2024, 8 (01) : 8 - 17
  • [38] Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization
    Budinetz, Tara H.
    Mann, Jessica S.
    Griffin, Daniel W.
    Benadiva, Claudio A.
    Nulsen, John C.
    Engmann, Lawrence L.
    FERTILITY AND STERILITY, 2014, 102 (03) : 753 - 758
  • [39] Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization
    Fornaro, Felice
    Cobellis, Luigi
    Mele, Daniela
    Tassou, Argyro
    Badolati, Barbara
    Sorrentino, Simona
    De Lucia, Domenico
    Colacurci, Nicola
    FERTILITY AND STERILITY, 2007, 87 (01) : 39 - 47
  • [40] A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix
    de Jong, D
    Macklon, NS
    Fauser, BCJM
    FERTILITY AND STERILITY, 2000, 73 (05) : 1051 - 1054